Lynderm Research Inc - Probity

Markham, Ontario L3P 1X3

0 studies enrolling now · 2 studies all time

What they study most

Plaque Psoriasis

Studies at this site

• A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis — Running, not enrolling
• A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis — Completed